Gehören Sie zu den Ersten, denen das gefällt!
Sri K. Sankaran (Winthrop & Weinstine, USA)
The pharmaceutical industry is going through a turmoil with death of many block buster drugs, increasing number of filers on NCE, pricing war, and stiff generic competition. All the Pharma companies are pursuing a Paragraph IV strategy to be competitive in the market. The reality is any Pharmaceutical product can be challenged. First-to-file comes with many advantage but you have to strategize/execute well to become first-to-market and beat the competition. This can be taken care effectively by involving external Law Firms and Search providers in Product targeting, ANDA filing strategy & support, E-discovery, Court proceedings, etc. Here the presenter would cover a case study on how external collaboration would help companies save time, costs and yet increase the success ratio.